Cited by 218Pituitary Gland Disorders and TreatmentsTraumatic Brain Injury and Neurovascular DisturbancesTraumatic Brain Injury Research

The DOI matches its Crossref record; 294 of the 310 references it cites were found in a registry or an index; 82 of the 506 sources its claims cite were checked for support.

Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach

Open access
Tanriverdi, Fatih, Schneider, Harald Jörn, Aimaretti, Gianluca, Masel, Brent E., Casanueva, Felipe F., Kelestimur, Fahrettin·2015·Endocrine Reviews

Abstract

Traumatic brain injury (TBI) is a growing public health problem worldwide and is a leading cause of death and disability. The causes of TBI include motor vehicle accidents, which are the most common cause, falls, acts of violence, sports-related head traumas, and war accidents including blast-related brain injuries. Recently, pituitary dysfunction has also been described in boxers and kickboxers. Neuroendocrine dysfunction due to TBI was described for the first time in 1918. Only case reports and small case series were reported until 2000, but since then pituitary function in TBI victims has been investigated in more detail. The frequency of hypopituitarism after TBI varies widely among different studies (15-50% of the patients with TBI in most studies). The estimates of persistent hypopituitarism decrease to 12% if repeated testing is applied. GH is the most common hormone lost after TBI, followed by ACTH, gonadotropins (FSH and LH), and TSH. The underlying mechanisms responsible for pituitary dysfunction after TBI are not entirely clear; however, recent studies have shown that genetic predisposition and autoimmunity may have a role. Hypopituitarism after TBI may have a negative impact on the pace or degree of functional recovery and cognition. What is not clear is whether treatment of hypopituitarism has a beneficial effect on specific function. In this review, the current data related to anterior pituitary dysfunction after TBI in adult patients are updated, and guidelines…

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review updates adult anterior pituitary dysfunction after traumatic brain injury, covering prevalence, sports- and blast-related injury, cognition, metabolism, pathophysiology, diagnosis, screening, and treatment. It reports that GH is the most frequently affected axis, that prevalence estimates vary with testing strategy, and that vascular, autoimmune, and genetic mechanisms are proposed but not fully established.

Key findings

  • In the authors’ systematic review of 16 studies and 1,291 TBI patients, pooled prevalence of any hormone deficiency without confirmatory testing was 28% and multiple deficiencies 6%; after confirmatory testing in 313 patients, these fell to 15% and 4%, with GH deficiency at 9%, ACTH at 6%, LH/FSH at 5%, and TSH at 1%.
  • A 5-year prospective study found persistent deficiencies at year five of 28% for GH, 4% for gonadotropin, and 4% for ACTH; GH was generally the most common deficit after TBI.
  • Sports-related repetitive head trauma was linked to pituitary dysfunction: 45% of amateur boxers had isolated GH deficiency in one study, kickboxers showed 22.7% GH and 9.1% ACTH deficiency with 27.3% having at least one anterior deficiency, and retired professional football players had 23.5% hypopituitarism, 50% metabolic syndrome, 19.1% GH deficiency, and 8.8% hypogonadism.
  • Proposed mechanisms include vascular injury, autoimmunity, and genetic susceptibility; APO E3/E3 genotype was associated with lower pituitary dysfunction (17.7% vs 41.9%, OR 0.29), and antipituitary/antihypothalamus antibodies were associated with persistent hypopituitarism in prospective follow-up.

Methods

  • This is a narrative review that also includes a systematic literature search of Medline through March 21, 2014, using terms for brain injury/TBI and hypopituitarism/pituitary, limited to human studies, with additional reference-list searches.
  • For prevalence, the authors included adult studies with stimulatory testing of GH and/or ACTH axes and more than three anterior pituitary deficiencies, excluded case reports/series under 10 patients, posterior pituitary or acute-phase-only studies, and analyzed 16 studies; 1,203 patients remained for chronic-phase prevalence and 313 were in the confirmatory-testing subset.
  • The review also synthesizes autopsy, radiological, experimental animal, sports, cognitive, metabolic, diagnostic, screening, and treatment literature.

Limitations

  • The authors state that included prevalence studies were heterogeneous in TBI severity, diagnostic tests, cutoffs, and preselection; most lacked control groups, only three had matched controls, and six studies reporting response rates had a 41% participation rate.
  • They note that long-term prospective studies had small samples, especially for moderate and severe TBI, and that autopsy findings came from fatal severe injuries, making generalization to nonfatal survivors difficult.
  • The text makes evident that many pathophysiological mechanisms and treatment benefits remain uncertain: confirmatory testing was available in only three studies, no large placebo-controlled trials establish GH replacement effects on rehabilitation or cognition after TBI, and recommendations for screening beyond 12 months need further confirmation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/er.2014-1065

Cites

294 of 294 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

176 No full text of the sources · 56 Own interpretation · 33 Own result · 32 Partly supported · 20 Supported · 19 No basis given · 18 Supported so far · 13 Not checked yet · 4 Sources not found · 4 Own method · 2 Not supported · 1 Couldn’t confirm · accuracy not yet measured

Verify all 11 references — free account

Show all 215 claims

  • Probably not a substantial claim. 49
  • It may state two separate claims as one. 124
  • The quote only partly states this claim. 7
163 of 163
  • The authors state this as an assumption.

    Relevant neuroendocrine dysfunction is present in only 6% of TBI survivors.

    “with the arbitrary assumption that relevant neuroendocrine dysfunction is present in only 6% of TBI survivors”
  • The authors state this as an assumption.

    Only those with multiple hormone deficiencies are relevantly affected by pituitary dysfunction.

    “for reasons of simplicity, assuming that only those with multiple hormone deficiencies are relevantly affected by pituitary dysfunction”
  • The authors state this as an assumption.

    Posttraumatic hypopituitarism poses a relevant burden to public health worldwide.

    “Therefore, we assume that posttraumatic hypopituitarism poses a relevant burden to public health worldwide.”
  • The paper relies on this without support.

    There are no clear data regarding the effects of sex hormone replacement on cognitive outcomes in patients with TBI-induced gonadotropin deficiency.

    “Additionally, there are no clear data regarding the effects of sex hormone replacement on cognitive outcomes in patients with TBI-induced gonadotropin deficiency.”
  • The paper relies on this without support.

    There are presently only a small but growing number of reports on the cognitive effects of GHD after TBI.

    “There are presently only a small (but growing) number of reports on the cognitive effects of GHD after TBI.”
  • The paper relies on this without support.

    Physical limitations and prolonged recovery are specific for TBI patients.

    “It should be taken into account that HDL cholesterol is mainly influenced by physical activity (89), and physical limitations and prolonged recovery are specific for TBI patients.”
  • The paper relies on this without support.

    Concussion is the most common clinical type of TBI.

    “Concussion is the most common clinical type of TBI.”
  • The paper relies on this without support.

    Few studies have investigated the pathophysiology of hypopituitarism during the acute phase of TBI.

    “Few studies have investigated the pathophysiology of hypopituitarism during the acute phase (generally the first 2 wk) of TBI.”
  • The paper relies on this without support.

    The pathophysiology of the reversibility of pituitary dysfunction is unclear.

    “Moreover, the pathophysiology of the reversibility of pituitary dysfunction is also unclear.”
  • The paper relies on this without support.

    Findings from experimental animal models of TBI can be extrapolated to human TBI-induced hypopituitarism.

    “This is an important experimental model for sportsrelated chronic repetitive mild TBI, and it supports the previous clinical data (38,46,48,179,180).”
    “However, further human studies are needed to understand the clinical relevance of these experimental findings.”
  • The paper relies on this without support.

    TBI is an important cause of hypopituitarism.

    “Because TBI is an important cause of hypopituitarism, it is tempting to suggest that the first approach should be testing all patients with a history of TBI.”
  • The paper relies on this without support.

    Global screening of all patients with a history of TBI is not cost-effective.

    “However, this strategy is not cost-effective and would result in unnecessary health resource consumption for a community.”
  • The paper relies on this without support.

    The diagnostic criteria and cutoffs for classical hypopituitarism are valid for TBI-induced hypopituitarism.

    “The diagnosis of TBI-induced hypopituitarism, defined as the deficient hormone secretion of one or more pituitary hormones because of TBI, is made similarly to the diagnosis of classical hypopituitarism because of hypothalamic or pituitary diseases.”
  • The paper relies on this without support.

    A morning plasma cortisol level ≤11 g/dL (300 nmol/L) is a valid diagnostic cutoff for ACTH deficiency during the acute phase after TBI.

    “we suggest a morning plasma cortisol level Յ11 g/dL (300 nmol/L) as the diagnostic cutoff for ACTH deficiency during the acute phase.”
  • The paper relies on this without support.

    Screening and treating hypopituitarism in TBI patients improves clinical outcomes.

    “We believe that awareness of TBI-induced hypopituitarism in the medical community may lead to early diagnosis and, therefore, early treatment of hypopituitarism.”
15 of 15

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 310 references

Research works printed but not linked: 5

  1. Cryan, 1918, Pituitary damage due to skull base fracture, Deutsche Medizinische Wochenschrift, 44, 1261
  2. Rouvillois, 1921, Lesions traumatiques de l'hypophyse dans les fractures de la bas du crane, Bull Mem Soc Chirurg Paris, 47, 685
  3. Schereschewsky, 1927, La symptomatologie et la diagnostic de la maladie de Simmonds (cachexie hypophysaire), Rev Franc Endocr, 5, 275
  4. Kraus, 2005, Epidemiology, 3
  5. Tanriverdi, 2013, Endocrinology of acute brain injury, 465

Cited by

Sorted by citations

Metadata

Authors
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F.
Affiliations
  • Erciyes University Medical School (F.T., F.K.), Department of Endocrinology, 38039 Kayseri, Turkey;
  • LMU Klinikum (DE)
  • Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
  • Transitional Learning Center (US)
  • Universidade de Santiago de Compostela (ES)
Venue
Endocrine Reviews
Published
2015-05-07
Volume
36
Issue
3
Pages
305-342
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2103564728
Cited by
218
References
310
Citations by year
2026: 18 · 2025: 21 · 2024: 20 · 2023: 14 · 2022: 22 · 2021: 15 · 2020: 15 · 2019: 29 · 2018: 21 · 2017: 18 · 2016: 16 · 2015: 9
FWCI
3.20
Type
journal article
Language
en
Open access
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
Funders
Erciyes Üniversitesi
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
Keywords
traumatic brain injury, hypopituitarism, anterior pituitary dysfunction, neuroendocrine dysfunction, growth hormone deficiency, ACTH deficiency, gonadotropin deficiency, thyroid-stimulating hormone deficiency, boxing, autoimmunity, genetic susceptibility, cognitive impairment, metabolic effects
MeSH terms
Brain Injuries, Humans, Pituitary Diseases, Pituitary Gland

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review